Course Objectives
At the conclusion of this course, participants should be better able to:
Provide a comprehensive overview of state-of-the-art multiparametric prostate magnetic resonance imaging.
Describe the benefit of prostate MR imaging for active surveillance and biopsy planning.
Understand how prostate MR imaging can improve focal therapy, prostatectomy, and radiation therapy planning.Discuss standardized reporting/PIRADS. Describe advances in prostatic mpMRI, including contrast enhancement, and diffusion weighted imaging as well as the optimal timing for performing mpMRI post-biopsy.
Evaluate and differentiate between different approaches for using MRI to guide prostate biopsy.
Discuss factors that enhance effectiveness of minimally invasive procedures and establish and utilize treatment strategies that decrease complications
Discuss the emerging role of urine and serum biomarkers to identify men at increased risk for harboring clinically significant prostate cancer
The conference will also be available via a realtime streaming webinar. For those unable to physically attend, you may still participate and earn CME credit via an online meeting room live webinar. You will be able to hear the speaker, see the slides and text questions in a chat window to still participate in any Q&A. After registering, please email Jodi Canapp at [email protected] to obtain the weblink, username and password.
Agenda
7:00 am: Breakfast/Registration/Check in
8:00 am: "Overview: Why Imaging - Where Have We Been" – Peter G. Schulam, MD PhD
State of the Art in Prostate Cancer Diagnosis
8:15am Prostate MR Imaging T2/Diffusion/Perfusion - Steffen Huber, MD
8:45am Prostate Pathology – Peter A. Humphrey, MD, PhD and Angelique Levi, MD
9:15am MRI-Guided Fusion Biopsy – Preston C. Sprenkle, MD
9:45am Current Controversies in Prostate Cancer Screening – Michael S. Leapman, MD
10:15am Break/Visit Technology Showroom
10:30am Biomarkers: Urine and Serum – Michael S. Leapman, MD
11:00am Case Presentation I Localized Prostate Cancer – Patrick A. Kenney, MD
MRI Review - Jeffrey C. Weinreb, MD
Biopsy: Walk through of Artemis Biopsy – Preston C. Sprenkle, MD
Pathology Review – Peter A. Humphrey, MD, PhD and Angelique Levi, MD
Treatment Options:
- How Imaging Informs Surgery – John W. Colberg, MD
- Imaging in Active Surveillance, Genomic Assays – Preston C. Sprenkle, MD
- Focal Therapy – Preston C. Sprenkle, MD
- Radiation Therapy – Sameer K. Nath, MD
- Targeted Treatments: Embolization, Injections of Agents - Raj R. Ayyagari, MD
12:00pm Discussion
12:30pm – 1:30pm Lunch/Visit Technology Showroom
1:30pm Keynote Speaker "“High Risk Prostate Cancer: Contemporary Treatment Paradigms, Outcomes, and Future Directions” - Daniel W. Lin, MD Professor and Chief, Urologic Oncology; Vice Chair of Research; Pritt Family Endowed Chair for Prostate Cancer Research; Director, IPCR; Department of Urology, University of Washington
2:30pm Advances in Medical Therapy of Advanced Disease – Daniel P. Petrylak, MD
3:00pm Break/Visit Technology Showroom
3:15pm Case Presentation II Advanced Prostate Cancer
MRI Review - Jeffrey C. Weinreb, MD
New NM/SPECT Imaging Techniques – Lawrence A. Saperstein, MD
Pathology Review – Peter A. Humphrey, MD, PhD and Angelique Levi, MD
Treatment Options:
- Surgery in M1 Disease – Patrick A. Kenney, MD
- Radiation in M1 or N1 Disease - James B. Yu, MD
- Advanced Therapeutic Trials – Daniel P. Petrylak, MD
4:15pm Discussion
4:45pm Adjourn
Accredidation/Designation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of the The Yale School of Medicine. The Yale School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Yale School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
It is the policy of Yale University School of Medicine, through its Center for Continuing Medical Education, to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All faculty participating in this symposium are required to disclose to the program audience any relevant financial relationship(s) they (or spouse/partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interest. The Center for Continuing Medical Education will ensure that any conflicts of interest are resolved before the educational activity occurs.
Cancellation Policy
All cancellations must be received via e-mail at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored. Email [email protected] for any cancellations or questions
For more information, visit our event page.
